4th Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Miscellaneous Tariff Bill (MTB).

Foreign entity interest: Astellas Phara, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
KEVIN MICHAEL KAPPEL —
ROBERT NEAL MARTIN New Legislative Assistant, U. S. Senator Max Cleland
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to the implementation of the Affordable Health Care Act; Issues related to drug safety and drug shortages.

Foreign entity interest: Astellas Phara, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
KEVIN MICHAEL KAPPEL —
JEREMY RABINOVITZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.